OPKO Health, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
OPKO Health, Inc. (OPK) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$50.01 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2014-11-07
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$50.01M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was -$26.08M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was -$45.09M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2013-12-31 was -$17.43M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2013 was -$117.35M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2012 was -$29.65M.
- OPKO Health, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2011 was -$6.46M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$50.01M 10-Q · filed 2014-11-07 | -$76.09M derived: sum of 2 quarters · filed 2014-11-07 | -$121.18M 10-Q · filed 2014-11-07 | -$138.61M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | -$26.08M 10-Q · filed 2014-08-11 | -$71.16M 10-Q · filed 2014-08-11 | -$88.60M derived: sum of 3 quarters · filed 2014-08-11 | -$149.40M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | -$45.09M 10-Q · filed 2014-05-09 | -$62.52M derived: sum of 2 quarters · filed 2014-05-09 | -$123.32M derived: sum of 3 quarters · filed 2014-11-07 | -$127.67M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | -$17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$78.23M derived: sum of 2 quarters · filed 2014-11-07 | -$82.58M derived: sum of 3 quarters · filed 2014-11-07 | -$117.35M 10-K · filed 2014-03-03 |
| 2013-09-30 | -$60.80M 10-Q · filed 2014-11-07 | -$65.15M derived: sum of 2 quarters · filed 2014-11-07 | -$99.92M 10-Q · filed 2014-11-07 | -$100.88M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | -$4.35M 10-Q · filed 2014-08-11 | -$39.12M 10-Q · filed 2014-08-11 | -$40.08M derived: sum of 3 quarters · filed 2014-08-11 | -$49.91M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | -$34.76M 10-Q · filed 2014-05-09 | -$35.73M derived: sum of 2 quarters · filed 2014-05-09 | -$45.56M derived: sum of 3 quarters · filed 2014-05-09 | |
| 2012-12-31 | -$966.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$10.79M derived: sum of 2 quarters · filed 2014-03-03 | -$29.65M 10-K · filed 2014-03-03 | |
| 2012-09-30 | -$9.83M 10-Q · filed 2013-11-12 | -$28.68M 10-Q · filed 2013-11-12 | ||
| 2011-12-31 | -$6.46M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |